PARAMUS, N.J.–(BUSINESS WIRE)–Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary delivery technologies, announced today that Chief Medical Officer Dr. Jamie Oliver, Pharm.D., will participate as a panelist at BioFuture 2026, taking place Oct. 27-28, 2026, in New York. Dr. Oliver will join fellow industry leaders to discuss the technologies shaping what comes next across the life sciences, including oncology, CNS,

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.